Pierre Amarenco Selected Research

Pierre Amarenco Research Topics

Disease

140	Stroke (Strokes) 05/2024 - 01/2002
78	Ischemic Stroke 05/2024 - 01/2003
46	Transient Ischemic Attack 12/2023 - 09/2004
34	Hemorrhage 01/2024 - 07/2003
18	Atherosclerosis 12/2023 - 04/2003
18	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
16	Atrial Fibrillation 05/2024 - 11/2007
15	Brain Infarction 01/2024 - 01/2002
14	Embolic Stroke 08/2020 - 05/2009
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 12/2005
13	Pathologic Constriction (Stenosis) 12/2020 - 04/2008
13	Myocardial Infarction 10/2019 - 01/2004
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 12/2004
9	Embolism (Embolus) 01/2021 - 09/2009
9	Carotid Artery Diseases 01/2020 - 12/2004
8	Infarction (Infarctions) 12/2021 - 04/2005
8	Hemorrhagic Stroke 01/2020 - 01/2004
6	Cerebral Infarction 01/2020 - 01/2014
6	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 12/2008
6	Dyslipidemias (Dyslipidemia) 01/2019 - 02/2011
6	Vascular Diseases (Vascular Disease) 01/2018 - 07/2003
5	Cerebral Hemorrhage 05/2024 - 03/2013
5	Brain Ischemia (Cerebral Ischemia) 12/2023 - 10/2014
5	Type 2 Diabetes Mellitus (MODY) 11/2022 - 10/2011
5	Hypertension (High Blood Pressure) 01/2022 - 04/2003
5	Diabetes Mellitus 11/2019 - 09/2005
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 07/2003
4	Thrombosis (Thrombus) 01/2024 - 01/2009
4	Heart Failure 12/2018 - 06/2013
4	Lacunar Stroke 01/2014 - 04/2005
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 08/2007
3	Atherosclerotic Plaque (Atheroma) 09/2019 - 01/2003
3	Ischemia 10/2014 - 01/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2014 - 12/2005
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2014 - 09/2009
3	Neoplasms (Cancer) 09/2005 - 01/2002
2	Neurologic Manifestations (Neurological Manifestations) 05/2024 - 03/2012
2	Hypertriglyceridemia 11/2022 - 12/2018
2	Inflammation (Inflammations) 12/2020 - 10/2014
2	Frailty 01/2020 - 01/2019
2	Peripheral Arterial Disease 12/2018 - 06/2013

Drug/Important Bio-Agent (IBA)

43	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 07/2003
37	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2003
31	CholesterolIBA 11/2022 - 04/2003
27	LDL CholesterolIBA 01/2023 - 09/2005
24	LipidsIBA 01/2023 - 01/2003
21	oxidized low density lipoproteinIBA 01/2023 - 12/2004
20	TicagrelorIBA 01/2023 - 12/2015
19	Atorvastatin (Lipitor)FDA Link 01/2020 - 10/2006
16	RivaroxabanIBA 01/2021 - 01/2014
15	AnticoagulantsIBA 01/2022 - 09/2004
13	Triglycerides (Triacylglycerol)IBA 11/2022 - 04/2009
12	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020 - 09/2004
11	HDL CholesterolIBA 11/2022 - 02/2008
11	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 07/2003
9	Clopidogrel (Plavix)FDA Link 12/2023 - 09/2004
9	HDL LipoproteinsIBA 11/2022 - 06/2009
8	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2007
6	Lipoproteins (Lipoprotein)IBA 07/2020 - 06/2009
6	Vitamin K FDA Link 11/2019 - 01/2014
5	Ezetimibe (Zetia)FDA Link 01/2023 - 01/2020
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2020 - 11/2008
5	Factor Xa (Coagulation Factor Xa)IBA 11/2019 - 01/2014
5	terutrobanIBA 03/2019 - 11/2011
4	Factor Xa InhibitorsIBA 05/2024 - 01/2014
4	Neuroprotective AgentsIBA 12/2020 - 07/2010
4	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 01/2014
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2017 - 12/2004
4	Fibric Acids (Fibrates)IBA 06/2011 - 01/2004
3	OsteopontinIBA 12/2020 - 09/2009
3	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 04/2010
3	omega-Chloroacetophenone (Mace)IBA 01/2018 - 04/2016
3	bococizumabIBA 01/2017 - 08/2016
3	Trinitrotoluene (TNT)IBA 11/2016 - 04/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 04/2013
3	Blood Glucose (Blood Sugar)IBA 06/2014 - 06/2011
3	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2011 - 06/2010
3	Antihypertensive Agents (Antihypertensives)IBA 05/2009 - 01/2003
2	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 11/2022 - 12/2018
2	Retinaldehyde (Retinal)IBA 12/2021 - 01/2016
2	CytokinesIBA 04/2021 - 07/2006
2	ResistinIBA 12/2020 - 12/2017
2	AdiponectinIBA 12/2020 - 12/2017
2	CD40 Ligand (CD40L)IBA 12/2020 - 12/2017
2	ChemokinesIBA 12/2020 - 04/2005
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2020 - 12/2017
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 04/2016
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2006
2	PPAR alphaIBA 01/2019 - 12/2018
2	Insulin (Novolin)FDA Link 01/2019 - 01/2015

Therapy/Procedure

61	Therapeutics 05/2024 - 01/2003
17	Secondary Prevention 01/2022 - 01/2004
5	Thrombectomy 12/2023 - 09/2009
5	Thrombolytic Therapy 06/2015 - 09/2004
3	Carotid Endarterectomy 01/2017 - 03/2011
2	Contraindications 01/2020 - 01/2019
2	Aftercare (After-Treatment) 12/2018 - 05/2013